294 related articles for article (PubMed ID: 19595117)
21. The efficacy for unresectable hepatocellular carcinoma may be improved by transcatheter arterial chemoembolization in combination with a traditional Chinese herbal medicine formula: a retrospective study.
Yu Y; Lang Q; Chen Z; Li B; Yu C; Zhu D; Zhai X; Ling C
Cancer; 2009 Nov; 115(22):5132-8. PubMed ID: 19672999
[TBL] [Abstract][Full Text] [Related]
22. [Transcatheter arterial chemoembolization combined with external radiation for primary liver cancer].
Guo W; Song M; Yu E
Zhonghua Zhong Liu Za Zhi; 1999 Jan; 21(1):25-8. PubMed ID: 11776790
[TBL] [Abstract][Full Text] [Related]
23. Subsegmental transcatheter arterial embolization for small hepatocellular carcinoma.
Itsubo M; Koike K; Tsuno S; Osada M; Komuro O; Shimada N; Okuda J; Fukada H; Okuaki Y; Kawabe T; Toda G
Hepatogastroenterology; 2002; 49(45):735-9. PubMed ID: 12063981
[TBL] [Abstract][Full Text] [Related]
24. Chemoembolization of hepatocellular carcinoma: results of a metaanalysis.
Geschwind JF; Ramsey DE; Choti MA; Thuluvath PJ; Huncharek MS
Am J Clin Oncol; 2003 Aug; 26(4):344-9. PubMed ID: 12902882
[TBL] [Abstract][Full Text] [Related]
25. Palliative techniques for hepatic cancer.
Ruan DT; Warren RS
Surg Oncol Clin N Am; 2004 Jul; 13(3):505-16, ix. PubMed ID: 15236732
[TBL] [Abstract][Full Text] [Related]
26. Treatment of hepatocellular carcinoma using arterial chemoembolization with degradable starch microspheres and continuous arterial infusion of 5-fluorouracil.
Ishida K; Hirooka M; Hiraoka A; Kumagi T; Uehara T; Hiasa Y; Horiike N; Onji M
Jpn J Clin Oncol; 2008 Sep; 38(9):596-603. PubMed ID: 18772170
[TBL] [Abstract][Full Text] [Related]
27. Long-term survival of patients with unresectable hepatocellular carcinoma treated with transcatheter arterial chemoinfusion.
Ha BY; Ahmed A; Sze DY; Razavi MK; Simpson N; Keeffe EB; Nguyen MH
Aliment Pharmacol Ther; 2007 Sep; 26(6):839-46. PubMed ID: 17767468
[TBL] [Abstract][Full Text] [Related]
28. Nonresectional therapies for hepatocellular carcinoma.
Liu CL; Fan ST
Am J Surg; 1997 Apr; 173(4):358-65. PubMed ID: 9136797
[TBL] [Abstract][Full Text] [Related]
29. [New therapeutic options in the treatment of hepatocellular carcinoma].
Martinotti R; Evangelista W; Goss M; Angelini F; Satolli MA
Minerva Med; 2001 Oct; 92(5):341-7. PubMed ID: 11675578
[TBL] [Abstract][Full Text] [Related]
30. [Percutaneous ethanol injection therapy for hepatocellular carcinoma].
Nakamura H; Suyama Y; Takayasu Y; Akaji H
Rinsho Hoshasen; 1990 May; 35(5):577-83. PubMed ID: 2166175
[TBL] [Abstract][Full Text] [Related]
31. Traditional Chinese medicine plus transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma.
Meng MB; Cui YL; Guan YS; Ying Z; Zheng MH; Yuan CK; Zhang RM
J Altern Complement Med; 2008 Oct; 14(8):1027-42. PubMed ID: 18990050
[TBL] [Abstract][Full Text] [Related]
32. [Infusion chemotherapy and chemoembolization of liver metastases from cancer of the alimentary tract].
Zeng H; Li H; Shi Z
Zhonghua Zhong Liu Za Zhi; 2000 Sep; 22(5):422-4. PubMed ID: 11778283
[TBL] [Abstract][Full Text] [Related]
33. The role of transcatheter arterial embolization for patients with unresectable hepatocellular carcinoma: a nationwide, multicentre study evaluated by cancer stage.
Huang YH; Chen CH; Chang TT; Chen SC; Chiang JH; Lee HS; Lin PW; Huang GT; Sheu JC; Tsai HM; Lee PC; Huo TI; Lee SD; Wu JC
Aliment Pharmacol Ther; 2005 Mar; 21(6):687-94. PubMed ID: 15771754
[TBL] [Abstract][Full Text] [Related]
34. Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer: the end of an era?
Mocellin S; Pilati P; Lise M; Nitti D
J Clin Oncol; 2007 Dec; 25(35):5649-54. PubMed ID: 18065736
[TBL] [Abstract][Full Text] [Related]
35. Percutaneous ethanol injection for liver metastases.
Riemsma RP; Bala MM; Wolff R; Kleijnen J
Cochrane Database Syst Rev; 2013 May; (5):CD008717. PubMed ID: 23728679
[TBL] [Abstract][Full Text] [Related]
36. Percutaneous ethanol injection under CT fluoroscopy for hypervascular hepatocellular carcinoma following transcatheter arterial embolization.
Hamuro M; Kaminou T; Nakamura K; Matsuoka T; Sakai Y; Morimoto A; Hayashi S; Nakamura A; Hatagawa M; Yamada R
Hepatogastroenterology; 2002; 49(45):752-7. PubMed ID: 12063984
[TBL] [Abstract][Full Text] [Related]
37. Adjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombus.
Peng BG; He Q; Li JP; Zhou F
Am J Surg; 2009 Sep; 198(3):313-8. PubMed ID: 19285298
[TBL] [Abstract][Full Text] [Related]
38. Multiple hepatic arterial injections of recombinant adenovirus p53 and 5-fluorouracil after transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: a pilot phase II trial.
Tian G; Liu J; Zhou JS; Chen W
Anticancer Drugs; 2009 Jun; 20(5):389-95. PubMed ID: 19287305
[TBL] [Abstract][Full Text] [Related]
39. Subphrenic abscess formation following superselective transcatheter chemoembolization for hepatocellular carcinoma.
Yokoi Y; Suzuki S; Sakaguchi T; Okumura T; Kurachi K; Konno H; Nakamura S
Radiat Med; 2002; 20(1):45-9. PubMed ID: 12002604
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of clodronate, pamidronate, and zoledronate in reducing morbidity and mortality in cancer patients with bone metastasis: a meta-analysis of randomized clinical trials.
Machado M; Cruz LS; Tannus G; Fonseca M
Clin Ther; 2009 May; 31(5):962-79. PubMed ID: 19539097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
